Tag archive
Browse every WeightEasy article tagged New Drug.
Use tag archives to move laterally through related articles. This is useful when you want narrower guidance than a broad category page, such as reviewing articles about a specific medication, symptom, or routine concept.
CagriSema is Novo Nordisk's most ambitious new obesity drug. It combines two separate hormone targeting mechanisms in a single weekly injection and Phase 3 data shows it significan...
Orforglipron is the most anticipated new GLP 1 drug of 2026. Developed by Eli Lilly, it is a once daily oral pill with no injection and no fasting requirements a combination that d...
Retatrutide is the drug that may redefine how the medical world thinks about weight loss. In one Phase 3 clinical trial, participants lost an average of 71.2 lbs (32.3 kg) over 68...